Intelligence · Drug directory
Pipeline & Investigational Drugs
Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
Quick answer
Pipeline & investigational drugs: NovaPharmaNews tracks 1,610 pharmaceutical drugs in this segment. Investigational and clinical-stage compounds without US or EU marketing approval — linked to ClinicalTrials.gov programs and congress coverage.
-
granisetron product
KYTRIL
-
grazoprevir hydrate
GRAZYNA
-
honey purified (use as additive only)
NULL
-
human chorionic gonadotrophin
BREVACTID 1500 I.E
-
hydroxybenzoate compound solution
NULL
-
ibandronate
BONDRONAT
-
imeglimin hydrochloride
TWYMEEG
-
inhalations
NULL
-
insulin degludec / insulin aspart
RYZODEG
-
insulin glargine [insulin glargine biosimilar 1]
INSULIN GLARGINE BS [LILLY]
-
insulin lispro + insulin lispro protamine
HUMALOG MIX25 KWIKPEN
-
insulin neutral human + insulin isophane human
HUMULIN 30/70
-
iodine
NULL
-
iodine alcoholic solution
NULL
-
iodine aqueous oral solution
NULL
-
ipragliflozin l-proline
SUGLAT INITIAL APPROVAL
-
iptacopan hydrochloride hydrate
FABHALTA
-
iron polymaltose
FERROSIG
-
ispaghula husk product
FYBOGEL
-
kaolin
NULL
-
kaolin and opium mixture
NULL
-
kaolin mixture
NULL
-
lactic acid
NULL
-
laninamivir octanoate hydrate
INAVIR INITIAL APPROVAL
Frequently asked questions
How many pipeline drugs are listed?
1,610 drug profiles match this regulatory segment in our published index.
Where does approval data come from?
Profiles combine FDA Drugs@FDA, EMA EPAR references, and regional authority feeds. See our data sources page for attribution.